CymaBay Therapeutics Inc.

(CBAY)

By |

Profile

CymaBay Therapeutics Inc is a biopharmaceutical company is focused on developing therapies to treat metabolic diseases with unmet medical need, including serious rare and orphan disorders. Its clinical development candidates are MBX-8025 and arhalofenate.

Contact Information

Website: www.cymabay.com
Main Phone: +1 510 293-8800
Address: 7999 Gateway Boulevard
Address 2: Suite 130
State: CA
City / Town: Newark
Country: USA
Postal Code: 94560

Issuer Information

Exchange: NSC
Employees: 21
NAICS: Pharmaceutical P
$ 1.98 $ 0.09 (4.76%)
Last Price 1.98 Change $ 0.09 Change % 4.76 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 1.86 High 2.00 Low 1.85 Prev Close 1.89
Last Trade Volume 148,026 52 Wk Hi 3.04 52 Wk Low 0.82
Market Cap 46.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 23,447,003.00 EPS (TTM) -1.09 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 13
Number of Buys 0 4
Number of Sells 0 9
Net Activity 0 16271
Last 10 Buys Shares
Patrick J. O¿Mara 1,000
Charles A. McWherter 1,000
Sujal Shah 1,000
Sujal Shah 1,000
Kurt von Emster 1,000
Kurt von Emster 1,000
Kurt von Emster 1,000
Harold E. Van Wart 1,000
Harold E. Van Wart 1,000
Sujal Shah 1,000
Last 10 Sell Shares
Carl S. Goldfischer 1,000
Carl S. Goldfischer 1,000
Carl S. Goldfischer 1,000
Carl S. Goldfischer 1,000
Carl S. Goldfischer 1,000
Carl S. Goldfischer 1,000
Carl S. Goldfischer 1,000
Carl S. Goldfischer 1,000
Carl S. Goldfischer 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 4 4 4 4
Low Target Price Estimate 2.25 2.25 2.25 2.25
Mean Target Price Estimate 3.42 3.42 3.42 3.42
Standard Deviation 1.01 1.01 1.01 1.01
Date of Most Recent Estimate 08/12/16 06/30/16 06/30/16 08/19/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 1 2
Moderate Buy 0 0 0 0
Hold 1 1 1 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.67 1.67 2 1